An announcement by DelMar Pharmaceuticals regarding its purchase of 760500 shares of common stock BіоPhаrmа Dіvе
A biopharma firm which focuses on the development & commercialization of novel cancer therapies, DelMar Pharmaceuticals Inc., made an announcement …